Drugs for Acute Necrotizing Pancreatitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 40)
| # |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
| 1 |
|
Chlorhexidine |
Approved, Vet_approved, Withdrawn |
Phase 4 |
|
55-56-1 |
2713 9552079 |
|
Synonyms:
1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide)
AVAGARD
CHLORHEXIDIN
CHLORHEXIDIN [CZECH]
CHLORHEXIDINE
CHLORHEXIDINUM
CHLORHEXIDINUM [INN-LATIN]
Cloresidina
CLORESIDINA [DCIT]
CLORHEXIDINA
CLORHEXIDINA [INN-SPANISH]
|
Dentisept
EXIDINE
HIBISTAT
Merfen-incolore
N-(4-CHLOROPHENYL)-1-3-(6-{N-[3-(4-CHLOROPHENYL)CARBAMIMIDAMIDOMETHANIMIDOYL]AMINO}HEXYL)CARBAMIMIDAMIDOMETHANIMIDAMIDE
N,N'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
NOLVASAN
PERIDEX
STERILON
SUTHOL
SUTHOOOL
|
|
| 2 |
|
Somatostatin |
Approved, Investigational |
Phase 4 |
|
38916-34-6, 51110-01-1 |
53481605 16129706 |
|
Synonyms:
(5S,8R,14R,17R,20R,23R,26R,29R,32R,35R)-38-[(2-{[(2R)-2-amino-1-hydroxypropylidene]amino}-1-hydroxyethylidene)amino]-20,35-bis(4-aminobutyl)-14,26,29-tribenzyl-7,10,13,16,19,22,25,28,31,34,37-undecahydroxy-32-[(C-hydroxycarbonimidoyl)methyl]-11-(1-hydroxyethyl)-17-[(1S)-1-hydroxyethyl]-8-(hydroxymethyl)-23-[(1H-indol-3-yl)methyl]-1,2-dithia-6,9,12,15,18,21,24,27,30,33,36-undecaazacyclononatriaconta-6,9,12,15,18,21,24,27,30,33,36-undecaene-5-carboxylate
ALA-GLY-CYCLO-[CYS-LYS-ASN-PHE-PHE-TRP-LYS-THR-PHE-THR-SER-CYS]
Growth hormone-inhibiting hormone (ghih)
L-ALANYLGLYCYL-L-CYSTEINYL-L-LYSYL-L-ASPARAGINYL-L-PHENYLALANYL-L-PHENYLALANYL-L-TRYPTOPHYL-L-LYSYL-L-THREONYL-L-PHENYLALANYL-L-THREONYL-L-SERYL-L-CYSTEINE CYCLIC (3-14) DISULFIDE
SOMATOSTATIN
SOMATOSTATIN-1
SOMATOSTATIN-14
SOMATOSTATINA
|
SOMATOSTATINE
SOMATOSTATINUM
Somatotropin release-inhibiting factor (srif)
Somatotropin release-inhibiting hormone
SRIF-14
SYNTHETIC GROWTH HORMONE RELEASE-INHIBITING HORMONE
SYNTHETIC SOMATOSTATIN-14
|
|
| 3 |
|
Cefoperazone |
Approved, Investigational |
Phase 4 |
|
62893-19-0 |
44185 44187 |
|
Synonyms:
(6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure
(6R,7R)-7-({(2R)-2-[(4-ETHYL-2,3-DIOXOPIPERAZINE-1-CARBONYL)AMINO]-2-(4-HYDROXYPHENYL)ACETYL}AMINO)-3-[(1-METHYLTETRAZOL-5-YL)SULFANYLMETHYL]-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID
(6R,7R)-7-[(2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)(hydroxy)methylidene]amino}-1-hydroxy-2-(4-hydroxyphenyl)ethylidene)amino]-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-[(2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)(hydroxy)methylidene]amino}-1-hydroxy-2-(4-hydroxyphenyl)ethylidene)amino]-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulphanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-[(2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)(hydroxy)methylidene]amino}-1-hydroxy-2-(4-hydroxyphenyl)ethylidene)amino]-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulphanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Céfobis
Cefoperazon
CEFOPERAZONE
Cefoperazone sodium
|
Cefoperazone sodium salt
Cefoperazono
Cefoperazonum
CPZ
Farmasierra brand OF cefoperazone sodium
Pfizer brand OF cefoperazone sodium
Salt, cefoperazone sodium
Sodium salt, cefoperazone
Sodium, cefoperazone
|
|
| 4 |
|
Metronidazole |
Approved |
Phase 4 |
|
443-48-1, 69198-10-3 |
4173 |
|
Synonyms:
1-(2-Hydroxy-1-ethyl)-2-methyl-5-nitroimidazole
1-(2-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(beta-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Oxyethyl)-2-methyl-5-nitroimidazole
1-(b-Ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(b-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(b-Oxyethyl)-2-methyl-5-nitroimidazole
1-(Î’-ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(Î’-hydroxyethyl)-2-methyl-5-nitroimidazole
1-(Î’-oxyethyl)-2-methyl-5-nitroimidazole
2 Methyl 5 nitroimidazole 1 ethanol
2-Methyl-1-(2-hydroxyethyl)-5-nitroimidazole
2-Methyl-3-(2-hydroxyethyl)-4-nitroimidazole
2-Methyl-5-nitroimidazole-1-ethanol
ACEA
Acromona
ANABACT
Anagiardil
Apo-Metronidazole
Arilin
Atrivyl
BAY-5360
Bayer 5360
BAYER-5360
Bexon
Clont
Cont
Danizol
Deflamon
Deflamon-Wirkstoff
DRAZIFON
Efloran
ELYZOL
Entizol
Eumin
Flagemona
Flagesol
Flagil
Flagyl
FLAGYL 375
FLAGYL COMPAK
FLAGYL ER
Flagyl I.V.
FLAGYL I.V. RTU IN PLASTIC CONTAINER
FLAGYL-400
FLAGYL-S
Flegyl
Fossyol
Giatricol
Gineflavir
Hydrochloride, metronidazole
Klion
Klont
Meronidal
Methronidazole
Metric
METRIC 21
Metro Cream
Metro I.V.
Metro I.V. In Plastic Container
METRO IV
METROCREAM
Metrodzhil
MetroGel
Metrogel-vaginal
Metrogyl
Metrolag
METROLOTION
METROLYL
|
METROMIDOL
Metronidaz
Metronidazol
METRONIDAZOLE
Métronidazole
Metronidazole benzoate
Metronidazole Hcl
Metronidazole hydrochloride
Metronidazole in plastic container
Metronidazole monohydrochloride
Metronidazole phosphate
Metronidazole phosphoester
Metronidazolo
Metronidazolum
METROSA
METROTOP
Mexibol
Monagyl
Monasin
Monohydrochloride, metronidazole
Nalox
Neo-Tric
NEUTRATOP
Nida
Nidagel
Noritate
Noritic acid
NORZOL
Novonidazol
NSC-50364
NSC-69587
NUVESSA
Orvagil
Phosphate, metronidazole
Phosphoester, metronidazole
PROTOSTAT
Rathimed
ROSICED
ROZEX
RP-8823
Sanatrichom
Satric
Takimetol
Trichazol
Trichex
Tricho Cordes
Trichocide
Tricho-Gynaedron
Trichomol
Trichopal
Trichopol
Tricocet
Tricom
Tricowas B
Trikacide
Trikamon
Trikojol
Trikozol
Trimeks
Trivazol
Vagilen
Vagimid
VAGINYL
VANDAZOLE
Vertisal
Wagitran
ZADSTAT
ZIDOVAL
ZYOMET
|
|
| 5 |
|
Dexmedetomidine |
Approved, Experimental, Vet_approved |
Phase 4 |
|
86347-14-0, 113775-47-6 |
68602 5311068 |
|
Synonyms:
(+)-4-((S)-a,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-Α,2,3-trimethylbenzyl)imidazole
(+-)-4-(a,2,3-Trimethylbenzyl)imidazole
(+-)-4-(alpha,2,3-Trimethylbenzyl)imidazole
(+-)-4-(Α,2,3-trimethylbenzyl)imidazole
(+)-MEDETOMIDINE
(±)-4-(α,2,3-trimethylbenzyl)imidazole
(S)-MEDETOMIDINE
Dexdor
Dexdor®|Igalmi® (dexmedetomidine sublingual film)|MPV 1440|Precedex®
DEXMEDETOMIDIN
Dexmedetomidina
DEXMEDETOMIDINE
DEXMÉDÉTOMIDINE
Dexmedetomidine hydrochloride
Dexmedetomidinum
|
Domitor
Hospira brand OF dexmedetomidine hydrochloride
Hydrochloride, dexmedetomidine
Hydrochloride, medetomidine
Levomedetomidine
Medetomidina
Medetomidina [Spanish]
Medetomidine
Medetomidine hydrochloride
Medetomidinum
Medetomidinum [Latin]
MPV 1440
MPV 785
MPV-1440
MPV-785
Precedex
|
|
| 6 |
|
Meropenem |
Approved, Investigational |
Phase 4 |
|
119478-56-7, 96036-03-2 |
441130 |
|
Synonyms:
(1R,5S,6S)-2-[(3S,5S)-5-DIMETHYLAMINOCARBONYLPYRROLIDIN-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylate
(1R,5S,6S)-2-[(3S,5S)-5-DIMETHYLAMINOCARBONYLPYRROLIDIN-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylIC ACID
(2S,3R,4R)-2-[(1S,2R)-1-CARBOXY-2-HYDROXYPROPYL]-4-{[(3S,5R)-5-(DIMETHYLCARBAMOYL)PYRROLIDIN-3-YL]SULFANYL}-3-METHYL-3,4-DIHYDRO-2H-PYRROLE-5-CARBOXYLIC ACID
(4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
(4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid
Antibiotic SM 7338
ICI-194660
MEPM
Meronem
MEROPENEM
Meropenem anhydrous
|
MEROPENEM HYDRATE
MEROPENEM TRIHYDRATE
Meropenemum
MEROPENEMUM TRIHYDRICUM
Merrem
Merrem i.v.
MERREM IV
Penem
Ronem
SM-7338
ZD3591
|
|
| 7 |
|
Thymalfasin |
Investigational |
Phase 4 |
|
62304-98-7 |
16167214 16130571 |
|
Synonyms:
4-({1-[(1-{[1-({5-amino-1-[(1-{[1-({5-amino-1-[(1-{[5-amino-1-({5-amino-1-[(3-carboxy-1-{[1-({1-[(3-carboxy-1-{[3-carboxy-1-({1-[(3-carboxy-1-{[1-carboxy-2-(C-hydroxycarbonimidoyl)ethyl]-C-hydroxycarbonimidoyl}propyl)-C-hydroxycarbonimidoyl]ethyl}-C-hydroxycarbonimidoyl)propyl]-C-hydroxycarbonimidoyl}propyl)-C-hydroxycarbonimidoyl]-2-methylpropyl}-C-hydroxycarbonimidoyl)-2-methylpropyl]-C-hydroxycarbonimidoyl}propyl)-C-hydroxycarbonimidoyl]pentyl}-C-hydroxycarbonimidoyl)pentyl]-C-hydroxycarbonimidoyl}-3-carboxypropyl)-C-hydroxycarbonimidoyl]pentyl}-C-hydroxycarbonimidoyl)-3-methylbutyl]-C-hydroxycarbonimidoyl}-2-carboxyethyl)-C-hydroxycarbonimidoyl]pentyl}-C-hydroxycarbonimidoyl)-2-hydroxypropyl]-C-hydroxycarbonimidoyl}-2-hydroxypropyl)-C-hydroxycarbonimidoyl]-2-methylbutyl}-C-hydroxycarbonimidoyl)-4-[(2-{[2-({2-[(3-carboxy-2-{[2-({2-[(2-{[3-carboxy-2-({1,3-dihydroxy-2-[(1-hydroxyethylidene)amino]propylidene}amino)-1-hydroxypropylidene]amino}-1-hydroxypropylidene)amino]-1-hydroxypropylidene}amino)-1-hydroxy-3-methylbutylidene]amino}-1-hydroxypropylidene)amino]-1,3-dihydroxybutylidene}amino)-1,3-dihydroxypropylidene]amino}-1,3-dihydroxypropylidene)amino]butanoate
TALPHA1
THYMALFASIN
THYMOSIN ALPHA 1
|
THYMOSIN ALPHA1
Thymosin alpha1 (human)
THYMOSINS THYMALFASIN
ZADAXIN
|
|
| 8 |
|
Hormones |
|
Phase 4 |
|
|
|
| 9 |
|
Antiprotozoal Agents |
|
Phase 4 |
|
|
|
| 10 |
|
Antiparasitic Agents |
|
Phase 4 |
|
|
|
| 11 |
|
Hormone Antagonists |
|
Phase 4 |
|
|
|
| 12 |
|
Disinfectants |
|
Phase 4 |
|
|
|
| 13 |
|
Anti-Infective Agents, Local |
|
Phase 4 |
|
|
|
| 14 |
|
Dermatologic Agents |
|
Phase 4 |
|
|
|
| 15 |
|
Sulperazone |
|
Phase 4 |
|
|
|
| 16 |
|
Chlorhexidine gluconate |
|
Phase 4 |
|
|
|
| 17 |
|
Adjuvants, Immunologic |
|
Phase 4 |
|
|
|
| 18 |
|
Immunologic Factors |
|
Phase 4 |
|
|
|
| 19 |
|
Antibiotics, Antitubercular |
|
Phase 4 |
|
|
|
| 20 |
|
Anti-Bacterial Agents |
|
Phase 4 |
|
|
|
| 21 |
|
Anti-Infective Agents |
|
Phase 4 |
|
|
|
| 22 |
|
Streptokinase |
Approved, Investigational |
Phase 2, Phase 3 |
|
9002-01-1 |
|
|
Synonyms:
Estreptoquinasa
KABIKINASE
STREPTASE
Streptochinasi
|
Streptococcal fibrinolysin
STREPTOKINASE
STREPTOKINASE C PRECURSOR
Streptokinasum
|
|
| 23 |
|
Fibrinolytic Agents |
|
Phase 2, Phase 3 |
|
|
|
| 24 |
|
Pharmaceutical Solutions |
|
Phase 1 |
|
|
|
| 25 |
|
Propofol |
Approved, Investigational, Vet_approved |
|
|
2078-54-8 |
4943 |
|
Synonyms:
2,6 Diisopropylphenol
2,6-Bis(1-methylethyl)phenol
2,6-Diisopropylphenol
2,6-diisopropylphenol|Diprivan®|ICI 35868
Abbott brand OF propofol
Alpha Brand OF propofol
Aquafol
Astra brand OF propofol
AstraZeneca brand OF propofol
Braun brand OF propofol
Curamed brand OF propofol
Diisopropylphenol
Diprivan
Disoprivan
Disoprofol
Fresenius brand OF propofol
Fresenius kabi brand OF propofol
Fresofol
ICI 35868
ICI 35-868
|
ICI35,868
ICI-35868
Ivofol
Juste brand OF propofol
NSC-5105
Parnell brand OF propofol
Pisa brand OF propofol
Propofol
Propofol abbott
Propofol fresenius
Propofol MCT
Propofol rovi
Propofol-lipuro
Propofolum
Rapinovet
Recofol
Rovi brand OF propofol
Schering brand OF propofol
Zeneca brand OF propofol
|
|
| 26 |
|
Fluorouracil |
Approved |
|
|
51-21-8 |
3385 |
|
Synonyms:
5 Fluorouracil
5 Fluorouracil biosyn
5 FU
5 FU lederle
5 FU medac
5 HU hexal
5.F.U.
5-Fluoracil
5-Fluoropyrimidine-2,4-dione
5-Fluorouracil
5-Fluorouracil-biosyn
5-Fluracil
5FU
5-FU
5-FU lederle
5-FU medac
5-HU hexal
ACCUSITE
ACTIKERALL
Adrucil
Allergan brand OF fluorouracil
Arumel
Biosyn brand OF fluorouracil
Carac
Carzonal
CSP Brand OF fluorouracil
Dakota brand OF fluorouracil
Dakota, fluorouracile
Dermatech brand OF fluorouracil
Dermik brand OF fluorouracil
Effluderm
Efudex
Efudix
Efurix
Ferrer brand OF fluorouracil
Fluoro Uracil
Fluoro uracile icn
Fluoroblastin
Fluoroplex
Fluorouracil
Fluorouracil gry
Fluorouracil mononitrate
Fluorouracil monopotassium salt
Fluorouracil monosodium salt
Fluorouracil potassium salt
FLUORO-URACIL ROCHE
Fluorouracil teva brand
|
Fluorouracile dakota
Fluoro-uracile icn
Fluorouracil-gry
Fluorouracilo
Fluorouracilo ferrer far
Fluorouracilum
Fluoruracil
Fluouracil
Fluracedyl
FLURACIL
Fluracilum
Fluri
Fluril
Fluro Uracil
Flurodex
Flurouracil
Ftoruracil
FU
Gry brand OF fluorouracil
Haemato brand OF fluorouracil
Haemato fu
Haemato-fu
Hexal brand OF fluorouracil
ICN brand OF fluorouracil
Kecimeton
Medac brand OF fluorouracil
Neocorp brand OF fluorouracil
Neofluor
NSC-19893
Onkofluor
Onkoworks brand OF fluorouracil
Pharmachemie brand OF fluorouracil monosodium salt
Phthoruracil
Phtoruracil
Queroplex
Ribofluor
Ribosepharm brand OF fluorouracil
Riemser brand OF fluorouracil
RO-29757
RO-2-9757
Roche brand OF fluorouracil
Teva brand OF fluorouracil
Timazin
TOLAK
Ulup
URF
|
|
| 27 |
|
Indomethacin |
Approved, Investigational |
|
|
53-86-1 |
3715 |
|
Synonyms:
{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetate
{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid
1-(p-Chlorobenzoyl)-5-methoxy-2-methylindole-3-acetate
1-(p-Chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid
Aconip
Amuno
Apo-Indomethacin
Argun
Arthrexin
ARTRACIN
ARTRACIN SR
Artrinovo
Artrivia
BERLIND 75 RET
Bonidin
Bonidon
Bonidon Gel
Catlep
Chibro-Amuno
Chrono-Indicid
Chrono-Indocid
Confortid
Dolcidium
Dolcidium Pl
Dolovin
Durametacin
Elmetacin
Flexin Continus
FLEXIN-25 CONTINUS
FLEXIN-50 CONTINUS
FLEXIN-75 CONTINUS
Hicin
Hydrochloride, indomethacin
Idomethine
IMBRILON
IMN
Inacid
Indacin
Indaflex
Indameth
Indmethacine
Indocid
Indocid Pda
INDOCID RET
Indocid Sr
Indocid®|Indocin®
INDOCID-R
Indocin
Indocin I.V
Indocin I.V.
INDOCIN SR
INDODERM
INDOFLEX
INDOLAR
INDOLAR SR
INDO-LEMMON
INDOMAX-25
INDOMAX-75 SR
Indomecol
|
Indomed
Indomee
Indomet 140
Indometacin
INDOMETACIN FARNESIL
Indometacina
Indometacine
Indometacinum
Indometacyna
INDOMETHACIN
Indomethacin hydrochloride
Indomethacine
Indomethacinum
Indomethancin
Indomethazine
Indomethegan
Indomethine
Indometicina
Indomo
INDOMOD
INDO-PAED
Indo-Phlogont
Indoptic
INDOPTOL
Indo-Rectolmin
Indorektal
Indo-Spray
Indo-Tablinen
INDOTARD MR 75
Indoxen
Inflazon
Infrocin
Inteban Sp
Lausit
LEDMECIN
Liometacen
MAXIMET SR
Metacen
Metartril
Methazine
Metindol
Miametan
Mikametan
MOBILAN
Novomethacin
Novo-Methacin
NSC-77541
Nu-Indo
Osmosin
PARDELPRIN MR
Reumacide
Rhemacin La
RHEUMACIN LA
RIMACID
Sadoreum
SLO-INDO
Tannex
TIVORBEX
Vonum
|
|
| 28 |
|
Pancrelipase |
Approved, Investigational |
|
|
53608-75-6 |
8519 |
|
Synonyms:
1,4-ALPHA-D- GLUCAN GLUCANOHYDROLASE
ACCELERASE
COTAZYM
COTAZYM-S
CREON
Endothall
Endothall dipotassium salt
Endothall disodium salt
Endothall disodium salt, (endo,endo)-isomer
Endothall, diammonium salt
ENTOLASE
ILOZYME
KU-ZYME HP
LIPANCREATIN
lipase
|
PA
Pancrealipase
PANCREASE
PANCREATIC ALPHA-AMYLASE PRECURSOR
Pancreatic extract pancrelipase
Pancreatic protease
Pancreatin
Pancreatinum
PANCRELIPASE
Pancrelipase (amylase
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
protease)
VIOKASE
ZYMASE
|
|
| 29 |
|
Cephalosporins |
|
|
|
|
|
| 30 |
|
Antimetabolites |
|
|
|
|
|
| 31 |
|
Immunosuppressive Agents |
|
|
|
|
|
| 32 |
|
Cola |
|
|
|
|
|
| 33 |
|
Analgesics |
|
|
|
|
|
| 34 |
|
Antirheumatic Agents |
|
|
|
|
|
| 35 |
|
Cyclooxygenase Inhibitors |
|
|
|
|
|
| 36 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
|
|
|
|
| 37 |
|
Analgesics, Non-Narcotic |
|
|
|
|
|
| 38 |
|
Anti-Inflammatory Agents |
|
|
|
|
|
| 39 |
|
Tocolytic Agents |
|
|
|
|
|
| 40 |
|
Pancreatin |
|
|
|
|
|
Interventional clinical trials:
(show all 50)
| # |
Name |
Status |
NCT ID |
Phase |
Drugs |
| 1 |
Escalade or Deseacalade Antibiotic Use in Severe Acute Pancreatitis |
Unknown status |
NCT01992198 |
Phase 4 |
cefoperazone + metronidazole;Somatostatin;Meropenem |
| 2 |
Dexmedetomidine Hydrochloride in the Prevention of Organ Failure Following |
Unknown status |
NCT02691598 |
Phase 4 |
Infusion |
| 3 |
Thymosin Alpha 1 in the Prevention of Pancreatic Infection Following Acute Necrotizing Pancreatitis |
Completed |
NCT02473406 |
Phase 4 |
Thymosin Alpha 1;normal saline |
| 4 |
A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis |
Completed |
NCT00061438 |
Phase 4 |
meropenem |
| 5 |
The Impact of Early Enteral Nutrition on the Clinical Outcomes of Severe Acute Pancreatitis Patients: A Randomized Control Trial |
Completed |
NCT00995098 |
Phase 4 |
|
| 6 |
Effect of Traditional Chinese Medicine on Gastrointestinal Function Recovery and Nutrition Support in Severe Acute Pancreatitis |
Unknown status |
NCT00508729 |
Phase 2, Phase 3 |
Qingyi granules |
| 7 |
Evaluation of Effect of Integrated Treatment by Traditional Chinese and Western Medicine for Severe Acute Pancreatitis |
Unknown status |
NCT00506337 |
Phase 2, Phase 3 |
Qingyi granules |
| 8 |
Phase 2/3 Study of Use of Streptokinase for Enhancement of Percutaneous Drainage of Pancreatic Necrosis |
Completed |
NCT01977118 |
Phase 2, Phase 3 |
streptokinase |
| 9 |
Randomized, Double-blind, Placebo Controlled Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses (Intravenous Bolus) and Constant Intravenous Infusion Over 7 Days of GSK3335065 in Healthy Adult Subjects |
Terminated |
NCT03245619 |
Phase 1 |
GSK3335065;Placebo |
| 10 |
Prophylactic Pancreatic Duct Stenting in Acute Necrotizing Pancreatitis: a Prospective Randomized Controlled Multicenter Study |
Unknown status |
NCT01767233 |
|
|
| 11 |
A Randomized Control Trial of Plastic Stents vs. NAGI Bi-flanged Metal Stent for Endoscopic Ultrasound Guided Drainage of Walled-off Necrosis |
Unknown status |
NCT04479228 |
|
|
| 12 |
A Randomized Controlled Trials on the Effect of Necrotic Cavity Lavage After Laparoscope-assisted Debridement for Patients With Infected Pancreatic Necrosis |
Unknown status |
NCT04275466 |
|
|
| 13 |
The Study of Laparoscopic-assisted Percutaneous Catheter-directed Drainage to Treat Early Severe Acute Pancreatitis in Chinese Population. |
Unknown status |
NCT02133014 |
|
0.5% 5-fluorouracil normal saline |
| 14 |
Study of Plasma mitDNA in Predicting Pancreatic Necrosis in Acute Pancreatitis |
Unknown status |
NCT03788928 |
|
|
| 15 |
Risk Factors for ARDS in Patients With Acute Necrotizing Pancreatitis |
Completed |
NCT02641964 |
|
|
| 16 |
Acute Necrotizing Pancreatitis and Infected Pancreatic Necrosis: Can we Predict Primary Drainage Failure? |
Completed |
NCT03234166 |
|
|
| 17 |
Randomized Trial Examining the Impact of Pancreatic Duct Stent Placement in Patients With Acute Necrotizing Pancreatitis in the Prevention of Walled-off Necrosis |
Completed |
NCT03115918 |
|
|
| 18 |
Significance of Collections Around Colon in Patients With Acute Necrotizing Pancreatitis: a Prospective Study |
Completed |
NCT03411629 |
|
|
| 19 |
Risk Factors and Outcomes of Infected Pancreatic Necrosis: Retrospective Cohort of 148 Patients Admitted to the ICU for Acute Pancreatitis |
Completed |
NCT03253861 |
|
|
| 20 |
Videoendoscopic Drainage of Infected Pancreatic Collections |
Completed |
NCT00061269 |
|
|
| 21 |
Clinical Research on the Prophylactic Efficacy of Pancreatic Duct Stenting Combined With Rectal Indomethacin Drug on Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis |
Completed |
NCT03643900 |
|
rectal indomethacin |
| 22 |
EUS-guided Drainage of Large Walled-off Pancreatic Necrosis Using Lumen Apposing Metal Stents or Standard Double Pigtail Technique. A Single-center, Open-label, Randomized, Superiority Trial |
Completed |
NCT04057846 |
|
|
| 23 |
Prospective, Trial Evaluating the Safety and Effectiveness of the Interscope Endorotor® System for Direct Endoscopic Necrosectomy of Walled Off Pancreatic Necrosis |
Completed |
NCT03694210 |
|
|
| 24 |
Randomized Multicenter Study Comparing Plastic Stents and Self-expanding Metallic Stents Used in the Eus-guided Transmural Drainage of Walled-off Pancreatic Necrosis. |
Completed |
NCT03100578 |
|
|
| 25 |
Randomized Trial Comparing Fully Covered, Self-Expanding Metal Stent and Plastic Stents for Endoscopic Ultrasound-guided Drainage of Walled-off Necrosis |
Completed |
NCT02685865 |
|
|
| 26 |
Radiological Predictors of Failure of Endoscopic Therapy or Need For Multiple Endoscopic Procedures in Patients With Walled Off Pancreatic Necrosis |
Completed |
NCT03801070 |
|
|
| 27 |
Minimally Invasive Surgery vs. Endoscopy Randomized (MISER) Trial for Necrotizing Pancreatitis |
Completed |
NCT02084537 |
|
|
| 28 |
EUS-guided Transenteric Drainage With a Novel Lumen-apposing Metal Stent for the Management of Pancreato-biliary Diseases: a Multi-national, Multicenter Prospective Study |
Completed |
NCT03002051 |
|
|
| 29 |
A Multicenter, Single-arm Study of Endoscopic Ultrasound-Guided Drainage of Walled-off Pancreatic Necrosis With Lumen-Apposing Metal Stents |
Completed |
NCT03525808 |
|
|
| 30 |
Early Percutaneous Continuous Irrigation Assisted Vacuum Drainage Combined With Transgastric Necrosectomy Using Lumen Apposing Metal Stents in Treatment of Severe Acute Pancreatitis |
Completed |
NCT05508828 |
|
|
| 31 |
Does Transmural Plastic Stenting Prevent the Recurrence of Pancreatic Fluid Collection After Metal Stent Removal in Walled Off Necrosis With Disconnected Pancreatic Duct Syndrome ? -Prospective Randomized Controlled Trial |
Completed |
NCT03436043 |
|
|
| 32 |
Molecular Analysis of Microbial DNA in Infected Necrotizing Pancreatitis |
Completed |
NCT01815489 |
|
|
| 33 |
Endoscopic Step-up Approach vs Aggressive Debridement of Large Pancreatic Walled-off Necrosis - A Single-center, Open-label, Randomized, Superiority Trial (ACCELERATE) |
Recruiting |
NCT05601687 |
|
|
| 34 |
Immediate Endoscopic Necrosectomy vs. On-demand Necroectomy in Infected Walled-off Pancreatic Necrosis |
Recruiting |
NCT05530772 |
|
|
| 35 |
Randomized Trial Comparing Immediate Endoscopic Necrosectomy vs. Step-up Endoscopic Interventions in Necrotizing Pancreatitis |
Recruiting |
NCT05043415 |
|
|
| 36 |
Observational Study of Patients Treated With Hot AXIOS® Prosthesis in Real Life Conditions - |
Recruiting |
NCT04782414 |
|
|
| 37 |
Fasciotens to Treat an Open Abdomen - a Prospective Cohort Study |
Recruiting |
NCT04033614 |
|
|
| 38 |
Dual-scopic Pancreatic Necrosectomy (DPN): Laparoscopic Pancreatic Necrosectomy (LPN) and Nephroscopic Pancreatic Necrosectomy (NPN) |
Recruiting |
NCT04443595 |
|
|
| 39 |
Immediate Necrosectomy vs. Step-up Approach After EUS-guided Drainage of Walled-off Necrosis: a Multicenter Randomized Controlled Trial (WONDER-01) |
Recruiting |
NCT05451901 |
|
|
| 40 |
coMpliAnce With evideNce-based cliniCal Guidelines in the managemenT of Acute biliaRy pancreAtitis |
Recruiting |
NCT04747990 |
|
|
| 41 |
COMPARISON OF OUTCOMES OF NAGI BI-FLANGED METAL STENT ALONE VERSUS NAGI BI-FLANGED METAL STENT WITH CO-AXIAL PLASTIC STENT FOR DRAINAGE OF WALLED-OFF PANCREATIC NECROSIS |
Recruiting |
NCT05632900 |
|
|
| 42 |
Direct Endoscopic Necrosectomy Versus Endoscopic Step-up Approach After Endoscopic Drainage of Walled-off Pancreatic Necrosis (WON) |
Recruiting |
NCT05252897 |
|
|
| 43 |
Use of the ABTHERA ADVANCEâ„¢ Open Abdomen Dressing in Patients With Necrotizing Pancreatitis |
Recruiting |
NCT04986943 |
|
|
| 44 |
Open Surgery for Necrotizing Pancreatitis in the Era of Minimally Invasive Approach: 10-year Experience in a High-volume Centre |
Active, not recruiting |
NCT04673552 |
|
|
| 45 |
Endoscopic Ultrasound-guided Drainage Using Lumen-apposing Metal Stent With or Without Coaxial Plastic Stent for Treatment of Walled-off Pancreatic Necrosis: a Prospective Randomised Study |
Active, not recruiting |
NCT03923686 |
|
|
| 46 |
A Randomized Trial Comparing Direct Endoscopic Necrosectomy vs. Step-up Transluminal Endoscopic Interventions in Infected Necrotizing Pancreatitis (DESTIN) |
Active, not recruiting |
NCT04113499 |
|
|
| 47 |
Management of Portoplenomesenteric Vein Thrombosis in Patients With Acute Pancreatitis : an Observational Study |
Not yet recruiting |
NCT04642794 |
|
|
| 48 |
Timing of Transmural Stent Removal in Necrotizing Pancreatitis Undergoing Endoscopic Transmural Necrosectomy: A Randomized Controlled Study |
Not yet recruiting |
NCT04963868 |
|
|
| 49 |
Randomized, Multi-Center, Comparative and Cost Effectiveness Study of a Lumen- Apposing, Covered, Self-Expanding Metal Stent (Axiosâ„¢) Versus Multiple Double Pigtail Stents in the Management of Walled Off Pancreatic Necrosis |
Terminated |
NCT02673541 |
|
|
| 50 |
Endoscopic Large Caliber Drainage vs. Complete Necrosectomy for Treatment of Walled-off Pancreatic Necrosis: A Prospective, Randomized Noninferiority Trial. |
Withdrawn |
NCT02564965 |
|
|
|
